Core Insights - Spartan Capital Securities, LLC acted as the sole placement agent for a $17 million private investment in public equity (PIPE) financing for Powell Max Limited [1][2] Financing Details - Powell Max Limited entered into a securities purchase agreement with accredited investors, agreeing to issue units consisting of one Class C ordinary share and a warrant to purchase Class A ordinary shares, with total gross proceeds of $17 million [2] - The purchase warrants have no specific term and an exercise price of $0.001 per Class A ordinary share, subject to adjustments [3] - The company plans to use $9.4 million of the net proceeds to repurchase 1,449,732 Class A ordinary shares from Bliss on Limited, with the remainder allocated for general corporate purposes [3] Company Overview - Powell Max Limited is a financial communications services provider based in Hong Kong, offering services that support capital market compliance and transaction needs for corporate clients [5] - The company's services include financial printing, corporate reporting, communications, and language support, catering to both domestic and international companies listed in Hong Kong [5]

Core Viewpoint - Hyperscale Data, Inc. has entered into a sales agreement with Spartan Capital Securities for an at-the-market equity offering program, allowing the company to raise up to $50 million in gross proceeds [1][2]. Group 1: Sales Agreement and Financial Details - Under the sales agreement, Hyperscale Data may offer and sell shares of its common stock with aggregate gross proceeds of up to $50,000,000 [2]. - The shares will be sold through ordinary brokers' transactions on the NYSE American or at prevailing market prices, providing flexible access to capital [2]. Group 2: Use of Proceeds - The majority of the net proceeds from the offering will be used to acquire Bitcoin and further develop the company's Michigan data facility [3]. - A portion of the proceeds may also support working capital and general corporate purposes [3]. Group 3: Company Overview - Hyperscale Data, Inc. is an AI data center company anchored by Bitcoin, operating a data center that mines digital assets and offers colocation and hosting services [8]. - The company has a wholly owned subsidiary, Sentinum, which operates the data center, and another subsidiary, Ault Capital Group, Inc., focused on acquiring undervalued businesses and disruptive technologies [8].

Core Viewpoint - Healthcare Triangle, Inc. has entered into a Sales Agreement with Spartan Capital Securities for an at-the-market offering program, allowing the company to raise up to $20 million through the sale of its common stock [1][2]. Group 1: Sales Agreement Details - The Sales Agreement was executed on November 18, 2025, enabling Healthcare Triangle to offer and sell shares with an aggregate market value of up to $20 million [2]. - Shares may be sold on the Nasdaq Capital Market or other trading venues at prevailing market prices, providing flexible access to capital for the company's operational and financial strategy [2]. Group 2: Company Focus and Support - Healthcare Triangle is focused on strengthening its platform and expanding capabilities in cloud-based healthcare solutions [3]. - Spartan Capital Securities expresses support for Healthcare Triangle through the ATM program, indicating a commitment to the company's capital markets initiatives [3]. Group 3: Regulatory Compliance - The shares offered under the ATM program will be issued pursuant to an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission [4].

Core Insights - Spartan Capital Securities, LLC announced the closing of the second tranche of a registered direct offering for Multi Ways Holdings Limited, a leading supplier of heavy construction equipment in Singapore and the surrounding region [1][4]. Group 1: Offering Details - The second tranche consisted of 9,000,000 ordinary shares priced at $0.165 per share, along with warrants to purchase an additional 9,000,000 ordinary shares, resulting in aggregate gross proceeds of $1,485,000 from this tranche [2]. - Combined with the first tranche, the total gross proceeds raised through the offering amount to $2,970,000 [2]. Group 2: Warrant Information - Each warrant is exercisable at $0.198 per share and will remain exercisable for five years from the date of issuance [3]. Group 3: Use of Proceeds - Multi Ways intends to use the net proceeds for working capital and general corporate purposes [3]. Group 4: Company Background - Multi Ways Holdings supplies a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, serving customers across Singapore, Australia, UAE, Maldives, Indonesia, and the Philippines [7].

Core Insights - Spartan Capital Securities, LLC announced the closing of a $1.5 million registered direct offering for Lixte Biotechnology Holdings, Inc. [1] - The offering involved the sale of 974,026 shares of Common Stock at a public offering price of $1.54 per share [2] - The gross proceeds of approximately $1.5 million will be used for general corporate purposes and working capital [3] Company Overview - Lixte Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on cancer drug development [2][8] - The company's lead compound, LB-100, is a first-in-class PP2A inhibitor that enhances the effectiveness of chemotherapy and immunotherapy [8] - Clinical trials are currently underway for Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma [8] Transaction Details - The offering was made under an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission [5] - Spartan Capital Securities served as the exclusive placement agent for this transaction [1][4] - The transaction reflects a focus on aligning innovative biotech companies with strategic capital for advancing therapies [4]

Core Insights - Spartan Capital Securities, LLC successfully completed a $3,788,000 private placement for Lipella Pharmaceuticals Inc. [1] - The proceeds will support Lipella's mission to develop innovative therapies for unmet medical needs and fund general corporate purposes [2] - Spartan Capital's CEO highlighted the strength of Lipella's vision and the firm's commitment to facilitating impactful investment opportunities [3] Company Overview - Lipella Pharmaceuticals is focused on developing groundbreaking clinical therapies aimed at significant medical needs [2] - Spartan Capital Securities is a full-service investment banking firm known for its expertise in capital raising and strategic advisory services [6] Transaction Details - Spartan Capital acted as the sole placement agent for the private offering [1][3] - Legal counsel for the transaction included Sichenzia Ross Ference Carmel LLP for the placement agent and Sullivan & Worcester LLP for Lipella Pharmaceuticals [3] - Further transaction details will be available in Lipella's Form 8-K to be filed with the U.S. Securities and Exchange Commission [4]

Group 1 - Spartan Capital Securities, LLC successfully completed a $3,788,000 private placement for Lipella Pharmaceuticals Inc. [1][2] - The proceeds will support Lipella's mission to develop innovative therapies for unmet medical needs and fund general corporate purposes [2] - Jonathan Kaufman, CEO of Lipella, is focused on advancing the company's clinical pipeline and transformative treatments [2] Group 2 - John Lowry, CEO of Spartan Capital, expressed honor in serving as the sole placement agent and highlighted Lipella's commitment to medical innovation [3] - The transaction reflects the strength of Lipella's vision and Spartan Capital's dedication to impactful investment opportunities [3] - Legal counsel for the transaction included Sichenzia Ross Ference Carmel LLP for the placement agent and Sullivan & Worcester LLP for Lipella [3] Group 3 - Further details on the transaction will be available in Lipella's Form 8-K, to be filed with the U.S. Securities and Exchange Commission [4] - The common shares and related warrants have not been registered under the Securities Act of 1933, limiting their sale until registration or exemption [5] - This press release does not constitute an offer to sell or solicit offers to buy the securities [6]

Core Insights - Spartan Capital Securities, LLC successfully completed a $15.2 million private placement for Healthcare Triangle, Inc. to support its expansion and digital transformation initiatives in the healthcare and life sciences sectors [1][2]. Group 1: Financial Details - The proceeds from the private placement will be utilized for strategic acquisitions, general corporate purposes, and working capital needs, enhancing Healthcare Triangle's mission in cloud enablement, cybersecurity, and data analytics solutions [2]. - Spartan Capital Securities played a significant role by placing $14.2 million of the total private placement, highlighting its strong position in the investment banking sector [2]. Group 2: Company Statements - John Lowry, CEO of Spartan Capital Securities, expressed honor in serving as Co-Placement Agent for Healthcare Triangle, emphasizing the company's leadership in digital innovation within healthcare and life sciences [3]. - The successful transaction reflects both Healthcare Triangle's strong vision and Spartan Capital's commitment to facilitating meaningful investment opportunities [3]. Group 3: Legal and Compliance - The securities involved in the offering, including common stock and various warrants, have not been registered under the Securities Act of 1933 or any state securities laws, and cannot be offered or sold in the U.S. without registration or an applicable exemption [4].

As filed with the Securities and Exchange Commission on April 16, 2024 Registration No. 333-276943 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form F-1 (Amendment No. 5) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Green Circle Decarbonize Technology Limited (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Cayman Islands 3585 Not Applicable (I.R.S. Employer Identification ...

As filed with the Securities and Exchange Commission on April 5, 2024 Registration No. 333-276943 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form F-1 (Amendment No. 4) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Green Circle Decarbonize Technology Limited (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Cayman Islands 3585 Not Applicable (I.R. ...